Women’s Digital Health Startup Bloomlife Raises $4M

One of our customers, Bloomlife, digital health company focused on improving the health of moms and babies, just announced the closing of a $4 million seed funding round led by investors Marc Benioff and Efficient Capacity, LanzaTech Ventures, MeusInvest, Hanmi IT, The Chernin Group, Kapor Capital, and Act One Ventures. This round brings Bloomlife’s total funding to $6M.

Over the past two years, Bloomlife has developed state-of-the-art, clinically validated sensor that can measure important health parameters of mom and baby from conception to birth. This technology fuels Bloomlife’s mission to revolutionize prenatal care by using crowdsourced data to better understand pregnancy and pregnancy complications.

Quicksand developed the first proof-of-concept prototype of this system 2 years ago. The potential for this technology has already garnered Bloomlife top honors as winner of the Extreme Tech Challenge on Sir Richard Branson’s Necker Island.

“Our company’s mission resonated with the judges,” said Eric Dy, CEO and co-founder of Bloomlife . “They understood how our technology could help this underserved market.”

Since their inception, Bloomlife has worked hard to form strategic partnerships that further their field of expertise. They have ongoing partnerships with the University of California, San Francisco (UCSF)’s Preterm Birth Initiative and the research teams at Stanford.

With the new funding, Bloomlife is focused on building out its commercialization efforts for its first product, a smart pregnancy wearable that automatically detects and tracks contractions which expectant moms can visualize on their smartphone. With their innovative technology, Bloomlife allows the expectant mom to better understand her body and gain peace of mind throughout the third trimester. “Every pregnancy is unique and expectant moms are looking for validation of what they are feeling. Boomlife provides an objective second opinion,” says Eric Dy. Bloomlife’s pregnancy wearable is only available through an exclusive Early Access Program on their website www.bloomlife.com until launch. Funding will also be used to accelerate commercialization of new features and seeking FDA clearance.